Track startup funding.
Find the investors behind it.

BOB raises $5.5M seed led by Mischief

BOB AI Holdings Corp announced $5.5M in seed funding led by Mischief in an October 23, 2026 release, following an October 22 founder interview. Other named participants were Peter Thiel, Codie Sanchez, Mark Pincus and Karman Ventures. Proceeds support product development, onboarding and hiring in Miami. Valuation, individual allocations and exact legal closing date were undisclosed. BOB is a fintech, not a bank.

Star Therapeutics announces $200M private financing

Star Therapeutics announced $200M in private financing on October 23, 2026, co-led by OrbiMed and Janus Henderson Investors, to advance preclinical programs and expand its pipeline. A lettered series and valuation were not disclosed. An unnamed sovereign wealth fund also participated. This is separate from Incyte's July acquisition of Vega; acquisition proceeds and contingent milestones are excluded.

Pathos AI closes $237M Series E led by Bristol Myers Squibb

Company-confirmed $237M Series E close at an approximately $3B post-money valuation. Bristol Myers Squibb led with unnamed existing investors. Separate Pathos payments to Tempus of up to $55M over five years are data-license costs, not financing proceeds. Announced October 23, 2026; individual investor allocations undisclosed.